NEXT Content Authoring
A prominent global pharmaceutical company, sought to enhance the efficiency of its digital content management for its brands spanning North America and Europe. Their primary objective was to streamline and automate the approval processes across various countries while facilitating the swift creation and integration of digital resources. However, they encountered several challenges. These included an antiquated and labor-intensive method for identifying digital assets, limited asset repurposing capabilities, fragmented asset distribution among brands, inadequate asset analytics, a lack of a dedicated digital search and discovery system, and a deficiency in well-defined and rule-based components.
It is key to understand the pharma landscape before diving into the solution
Standard drug lifecycle
The lifecycle of a drug can be divided into several key stages, starting with drug discovery and development. In this initial phase, researchers identify and test potential compounds for their therapeutic properties. Promising candidates move on to preclinical studies, where their safety and efficacy are evaluated in laboratory and animal models. Once a drug shows potential, it progresses to clinical trials, which involve three phases of testing in human subjects to determine safety, dosage, and effectiveness. Regulatory agencies like the FDA closely review trial data, and if the drug is approved, it enters the market.
After market approval, the drug enters the post-marketing phase, during which its safety and effectiveness are continuously monitored in a real-world setting. The drug's manufacturer may also seek additional approvals for new uses or formulations. Eventually, as patents expire, generic versions of the drug become available, leading to increased competition and potentially lower prices. Throughout its lifecycle, a drug's success depends on its ability to meet medical needs, demonstrate safety, and deliver a positive benefit-risk profile for patients.
Cost Involved
Average cost to research & develop each successful drug is ~$ 2.6 Billion
Steps Involved
Discovery and Development, Pre-clinical research, Clinical Research, HA review, HA post-market safety monitoring
Drug discovery - Content lifecycle
Key challenges in the pharma industry around content creation
Why we need Module Manager?
Key personas involved
Pharma company
Pharmaceutical companies hold multifaceted responsibilities in drug content approval. They provide essential clinical data derived from trials, ensure compliance with regulatory guidelines, communicate product risks and benefits effectively, and collaborate with creative agencies to create engaging, informative content suited to the target audience.
Design Agency
Pharmaceutical companies face the challenging task of bridging the gap between complex scientific data and the general audience, a task that necessitates collaboration with creative agencies. However, this partnership can be costly, particularly due to the iterative nature of the content development process. Creative agencies must possess in-depth knowledge of the pharmaceutical industry, regulatory requirements, and the nuances of communicating medical information effectively. Their expertise is vital in creating content that meets both regulatory standards and engages the target audience, making their involvement indispensable despite the associated expenses.
Health Authority
The Health Authority, such as the FDA or EMA, safeguards drug safety and efficacy. They offer regulatory guidance, make final approval decisions, and engage in collaborative feedback and communication with pharma companies.
Competitor Analysis
What module manager does in simple terms
One of the aims of Module Manager is to establish a standardized template for modular content creation while allowing room for individual component customization. This could also serve as a distinct selling point within Module Manager's product offerings when compared to our competitors, who currently provide standardized templates at the final asset level.
Approach to establishing a Module Manager standard Modular Content Template includes:
Defining a template for creating standardized Modular Content.
Outlining the modular structure's layout with reference to existing standard templates.
Incorporating component-level distribution within the modular layout.
Sample marketing tactic & module generation
Information Architecture
The UX Flow
Click here to view prototype
What Next?
The next steps involve the introduction of a unified suite offered by Indegene, which comprises essential components such as Module Manager, Content Studio, Email, Banner, and eDetail. This integrated suite promises a comprehensive and streamlined solution for managing and optimizing content across various digital platforms in the pharmaceutical and healthcare industry. With Module Manager at its core, the suite ensures the creation of standardized modular content templates while allowing for individual customization. Content Studio complements this by enabling efficient content creation, editing, and management. The Email and Banner modules enhance targeted communication and outreach, while eDetail provides a specialized platform for engaging with healthcare professionals. Together, this unified suite promises a holistic approach to content management, offering the pharma industry a competitive advantage in delivering valuable, compliant, and engaging content.